Pharma Stocks
-
How Investors Are Reacting To Daiichi Sankyo Company (TSE:4568) New Real-World Bempedoic Acid Cardiovascular Data
Daiichi Sankyo recently reported new real-world data from the multinational MILOS study at the European Society of Cardiology 2026 Congress…
Read More » -
What Chugai Pharmaceutical (TSE:4519)’s Agentic AI Partnership With Phylo Means For Shareholders
Earlier in 2026, Chugai Pharmaceutical began rolling out an agentic AI platform across its drug discovery workflow and entered a…
Read More » -
Analysts Have Made A Financial Statement On Botanix Pharmaceuticals Limited’s (ASX:BOT) Yearly Report
Botanix Pharmaceuticals Limited (ASX:BOT) just released its latest yearly report and things are not looking great. It was a pretty…
Read More » -
Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter
Gaithersburg, Maryland–(Newsfile Corp. – August 28, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (the “Company” or “Shuttle”), today announced…
Read More » -
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma Company announcement – No. 43 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging…
Read More » -
Ascletis Pharma (SEHK:1672) Flags A Wider H1 2026 Loss, Is It Fully Priced?
Ascletis Pharma (SEHK:1672) told investors it expects a larger loss for the six months to June 30, 2026, as higher…
Read More » -
This Pharma Stock’s USD 14 Million Bet on Next-Generation Organ Transplantation
Company overview: Natco Pharma Limited (NSE: NATCOPHARM) is an India-based pharmaceutical company focused on research, development, manufacturing, and marketing of…
Read More » -
Ascendis Pharma (ASND) Shares Week 104 Data As FDA Clears Pediatric Achondroplasia Drug
Ascendis Pharma (NasdaqGS:ASND) presents Week 104 pivotal data on TransCon CNP (navepegritide) in achondroplasia at ISDS 2026, highlighting durable clinical…
Read More » -
REGN DEADLINE: SueWallSt Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
REGN DEADLINE: SueWallSt Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline Control-person liability allegations focus on Regeneron…
Read More » -
Trade Alert: Chief Medical Officer Of UroGen Pharma Mark Schoenberg Has Sold Stock
We wouldn’t blame UroGen Pharma Ltd. (NASDAQ:URGN) shareholders if they were a little worried about the fact that Mark Schoenberg,…
Read More »